CClinicalTrials.gg
RecruitingNCT05955339CHRONICLEUpdated May 18, 2026

Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults

An interventional study of NOTES and AUDIO in Diabetes Mellitus and Hypertension, sponsored by Dartmouth-Hitchcock Medical Center. Recruiting at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
1,022
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

CHRONICLE is a randomized trial assessing the comparative effectiveness of providing written visit information via the patient portal (NOTES) versus NOTES plus visit audio recording (AUDIO) to older adult patients with chronic diseases on quality of life and other outcomes. During the trial, the team will also invite caregivers identified by patients to join the project.

Read the detailed description

The research team is working with primary care clinics at three health systems across the country to enroll adults ages 65 and older who are managing diabetes or high blood pressure, plus one other disease. The team is assigning patients by chance to one of two groups. Each group will have an equal numbers of patients. Patients in one group will get access to visit notes through the patient portal. The research team will give patients guidance on how to find and use their visit notes. Patients in the other group will not only have access to their visit notes patients but also get access to audio-recordings of their visits. After each visit, patients in both groups will receive emails to review their visit information: 1) two days after their visit to remind them of their visit discussion and any tasks they may have, and 2) three days before their next visit, they will be asked to think of any changes from their last visit and to make a list of three things they want to talk to their doctor about. The team is comparing changes reported by patients over six months in quality of life, satisfaction, self-management ability, treatment adherence, and visit communication. The team will also invite caregivers identified by patients to join the project. They will show patients how to share their visit notes or recordings with caregivers. Caregivers will report on changes in how prepared they feel to provide care, burden related to caregiving, and how much they felt part of the patient's visit conversation.

02

Conditions studied

  • Diabetes Mellitus
  • Hypertension

Keywords

  • Audio Recording
  • Diabetes Mellitus
  • Hypertension
  • Patient-centered communication
  • Self-management
  • Older adults
  • Chronic conditions
  • After visit summary
  • Quality of life
  • Multimorbidity
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,318 are open to participants now.

This study's planned enrollment of 1,022 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Dartmouth-Hitchcock Medical Center is the lead sponsor of 472 studies on the registry; 68 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 20 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

PATIENTS:

Inclusion Criteria:

  • ≥ 65 years;
  • With multimorbidity (diabetes or hypertension plus one of the following: arthritis (osteoarthritis and rheumatoid arthritis), asthma, atrial fibrillation, Alzheimer's disease and related dementia (not severe), cancer, chronic obstructive pulmonary disease, depression, heart disease, heart failure, hyperlipidemia, osteoporosis, kidney disease and stroke. Patients with diabetes plus hypertension are eligible.
  • Have had two or more clinic visits in the previous 12 months;
  • Plan on receiving ongoing care at the clinic with the enrolled clinician for the subsequent 6 months;
  • Do not have vision or hearing problems that cannot be corrected; and
  • Have not recorded a clinic visit for personal use in the past 6 months

Exclusion Criteria:

  • With no capacity to consent to the project;
  • With schizophrenia and other psychotic disorders, current substance-use disorders, uncorrected hearing or visual impairment with no adjustments to support accessing the interventions or surveys;
  • Living in skilled nursing homes or hospice, because they engage less in self-management;
  • With cognitive impairment as identified by a score of ≤4 on the six-item screener (SIS)
  • Lacking internet access;
  • Who do not speak English or Spanish;
  • Who (i) do not have access to a personal email, (ii) do not have an email address shared with a family member or patient-identified caregiver, and/or (iii) are not interested in creating a personal email as this would prevent them from engaging with the intervention(s); and
  • Who do not wish to create a patient portal account, if they do not already have one as this would prevent them from engaging with the intervention(s).

CAREGIVERS:

Inclusion criteria:

  • Agree to their identified role as a caregiver;
  • Speak English or Spanish;
  • Have capacity to consent to research participation; and
  • ≥ 18 years.

Exclusion criteria:

  • No capacity to consent to the project;
  • Living in skilled nursing homes or hospice;
  • Lacking internet access; or
  • Do not speak English or Spanish
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,022 participants (estimated)

Study arms

  • Active comparator
    NOTES

    Patients in this arm will receive only the NOTES intervention.

    Other: NOTES

  • Active comparator
    NOTES + AUDIO

    Patients in this arm will receive both the NOTES and AUDIO intervention.

    Other: NOTES · Other: AUDIO

Interventions

  • OtherNOTES

    The intervention will include: (1) a brief training on using the patient portal to access written visit information with assistance in setting up patient portal accounts where necessary (including strategies to share notes with a caregiver), (2) post-visit reminders to use the patient portal to access written visit information.

  • OtherAUDIO

    The intervention will include: (1) audio recording all visits with the study clinician for six months, (2) training on how to record visits and access visit recordings, and (3) post-visit reminders listen to the visit recordings.

06

What researchers measure

Primary outcomes

  1. Quality of Life - Mental functioning

    Quality of life using Global PROMIS (Patient-Reported Outcome Measurement Information System) is a 10-item patient reported measure with two domains: mental and physical health. Domain scores range from 4 to 20, with higher scores representing better health.

    Time frame: 6 months from enrollment

  2. Quality of Life - Physical functioning

    Quality of life using Global PROMIS (Patient-Reported Outcome Measurement Information System) is a 10-item patient reported measure with two domains: mental and physical health. Domain scores range from 4 to 20, with higher scores representing better health.

    Time frame: 6 months from enrollment

Secondary outcomes

  1. Self-management ability

    Self-management ability using the Patient Activation Measure-Short Form is a 13-item patient reported measure. Scores are range from 0 (low activation) to 100 (high activation).

    Time frame: 6 months from enrollment

  2. Medication adherence

    Medication adherence using Adherence to Refills and Medications (ARMS-7), an seven-item measure with two domains: i) medication taking and ii) medication refilling. ARMS-7 scores range from 7 (high adherence) to 28 (low adherence).

    Time frame: 6 months from enrollment

  3. General satisfaction

    General satisfaction using the two-item general satisfaction sub-scale from the Patient Satisfaction Questionnaire-18 (PSQ-18). The subscale is scored as a mean of the two questions with a potential score ranging from 1 to 5. Higher scores indicate more satisfaction.

    Time frame: 6 months from enrollment

  4. Visit communication style and shared decision-making

    Visit communication style and shared decision making using 14 items (6 of 7 subscales) from the Interpersonal Process of Care (IPC) survey. Each of the 6 subscales has a potential score of 1 to 5. Direction of the score depends on the subscale.

    Time frame: 6 months from enrollment

Other outcomes

  1. Caregiver preparedness [Caregiver outcome]

    Caregiver preparedness using the 9-item Preparedness for Caregiving Scale. Scores range from 0 to 4 with higher scores corresponding to caregivers feeling more prepared for caregiving.

    Time frame: 6 months from enrollment

  2. Caregiver burden [Caregiver outcome]

    Caregiver burden using the 10-item Burden Scale for Family Caregivers-Short Form (BSFC-s). BSFC-s scores range from 0 to 30 with higher scores indicating greater caregiver burden.

    Time frame: 6 months from enrollment

  3. Caregiver engagement in clinic visit [Caregiver outcome]

    Caregiver engagement in clinic visit using the 12-item CAregiver Perceptions About CommunIcaTion with Clinical Team members (CAPACITY). Potential scores range from 12 to 48 with higher score indicating perceptions of better quality communication and capacity-assessment from the care team.

    Time frame: 6 months from enrollment

07

Study locations

2 of 3 sites recruiting
  • Dartmouth Hitchcock Clinics Manchester
    Manchester, New Hampshire 03104, United States
    Recruiting
  • Vanderbit University Medical Center
    Nashville, Tennessee 37232, United States
    Recruiting
  • University of Texas Medical Branch
    Galveston, Texas 77555, United States
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Upon completion of this research, the research data from this project will be deposited with the Patient-Centered Outcomes Data Repository (PCODR), based at the Inter-university Consortium for Political and Social Research (ICPSR), University of Michigan to ensure that the research community has long-term access to the data. This will include all deidentified data from surveys and/or transcripts from recorded interviews or encounters. For those who consent, we will also put identifiable recordings into the repository.

Supporting information: Study protocol, Icf

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05955339
Lead sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
The University of Texas Medical Branch, Galveston, Vanderbilt University Medical Center, Beth Israel Deaconess Medical Center, Patient-Centered Outcomes Research Institute
Responsible party
Paul J. Barr (Associate Professor, Trustees of Dartmouth College) — Principal investigator
First posted
Jul 21, 2023
Start date
Jan 24, 2024
Primary completion
Apr 7, 2027 (estimated)
Completion
Jun 14, 2027 (estimated)
Last update
May 18, 2026

Study contacts

Paul J Barr, PhD
Contact
paul.j.barr@dartmouth.edu
603-646-7016
Renata W. Yen, PhD
Contact
renata.west.yen@dartmouth.edu
603-646-5670
Paul J Barr, PhD
principal investigator · Dartmouth College
Kerri L Cavanaugh, MD
principal investigator · Vanderbilit University Medical Center
Meredith C Masel, PhD
principal investigator · University Texas Medical Branch

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion